Jun 2006 ~ March 2009

Funding

20 billion kwon (government 12 billion kwon, Neurotech 8 billion kwon)

Mission

Completion of AAD-2004 development through clinical phase I

Establishment of Global New Drug Development Infrastructure for the treatment of brain disease
Construction of new drug development system through collaborations with industry, academia, institutes, and
government
Entrance domestically and internationally for clinical studies and the verification of drug candidate superiority
Development of the first drug in the world to prevent the progression of Alzheimer's disease